COVID-19 Vaccine-Induced Myocarditis: The Majority Were Hospitalized

Citation: Rose, Jessica, & McCullough, Peter. (2022). Determinants of COVID-19 Vaccine-Induced Myocarditis Requiring Hospitalization. new window)

New paper by Jessica Rose, PhD and Peter McCullough, MD. We have been hearing from the Mainstream Media (MSM) that myocarditis cases from the vaccines are not serious, that they are mild cases. This study that you can read at the link above or on Rose’s website (Unacceptable Jessica)(opens new window) shows otherwise.

Here are their results and conclusions from the study:

Results: 3569/3594 (99.3%) cases of COVID-19 vaccine-induced myocarditis requiring hospitalization reports analyzed in the VAERS domestic data set were not co-associated with COVID-19 respiratory illness in accordance with either ‘negative’ polymerase chain reactions (PCR) to detect SARS-CoV-2, COVID-19 diagnosis, or both. Rates of hospitalization were high with 84% of all myocarditis reports associated with hospitalization in the 0-19 age group and 70.9, in general. Myocarditis in the context of co-presentation of elevated cardiac troponin (cTn), chest pain (CP), abnormal cardiac imaging , electrocardiogram ST segment elevation (STE) and abnormal C-reactive protein levels (CRP) was reported in the context of hospitalization in 92.2%, 85.5%, 93.5%, 93.9% and 90.3%, respectively, in children ages 0-19. 79% of all myocarditis requiring hospitalization reports were made within 7 days of injection and 48% were reported within 48 hours of injection. 90% of all myocarditis requiring hospitalization reports and 58% of reports were filed within 7 days and 48 hours, respectively in children ages 0-19. Higher reporting rates of troponin elevation, ST segment elevation and CRP abnormalities were found in 12-18-year-olds when compared to the next highest rates found in 19-29-year-olds (chi-sq; p = 0.00000000; p = 0.00000000; p = 0.00000006).  The independent predictors of hospitalization were as follows: male gender, OR=1.81, 95% CI 1.68-1.95, p<0.005; age (0-19 vs. 19+) OR=2.32, 95% CI 2-2.69, p<0.005; elevated troponin (12-18 vs. all other age groups), OR=4.63, 95% CI 3.59-5.99, p<0.005; an ST elevation (12-18 vs. all other age groups), OR=4.62, 95% CI 2.99-7.13, p<0.005.

Conclusions: Among those with COVID-19 vaccine-induced myocarditis, the majority were hospitalized, and the independent predictors of hospitalization were age, male gender, positive troponin, and ST-segment elevation on the ECG. Temporal proximity of reporting to injection date and significantly higher reporting rates of cardiac troponin, electrocardiogram ST segment elevation and abnormal C-reactive proteins in young individuals (12-18) in the context of myocarditis requiring hospitalization indicate that these particular pathognomonic markers may be linked to incipient heart failure whereby the injury due to the injection is the reason for the hospitalization, and should always be measured and used as diagnostic markers for COVID-19 vaccine-induced myocarditis.

The full report goes far more in depth and has some nice charts to visualize these findings along with a list of 101 references.


As censorship increases also consider using email and text messages to send links.

Leave a Reply

Your email address will not be published. Required fields are marked *